These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35268038)

  • 21. Influence of increased physical activity without body weight loss on hepatic inflammation in patients with nonalcoholic fatty liver disease.
    Asada F; Nomura T; Hosui A; Kubota M
    Environ Health Prev Med; 2020 Jun; 25(1):18. PubMed ID: 32522147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leisure-Time Physical Activity and Metabolic Syndrome in Older Adults.
    Gallardo-Alfaro L; Bibiloni MDM; Mateos D; Ugarriza L; Tur JA
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
    Chien-Min K; Cheng-Chuan L
    Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
    Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
    Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
    Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
    Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
    Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
    Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
    Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease.
    Chen J; Duan S; Ma J; Wang R; Chen J; Liu X; Xue L; Xie S; Yao S
    Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):754-761. PubMed ID: 32091437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased physical activity may be more protective for metabolic syndrome than reduced caloric intake. An analysis of estimated energy balance in U.S. adults: 2007-2010 NHANES.
    Frugé AD; Byrd SH; Fountain BJ; Cossman JS; Schilling MW; Gerard P
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):535-40. PubMed ID: 25960399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
    Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome.
    Bullón-Vela V; Abete I; Zulet MA; Xu Y; Martínez-González MA; Sayón-Orea C; Ruiz-Canela M; Toledo E; Sánchez VM; Estruch R; Lamuela-Raventós RM; Almanza-Aguilera E; Fitó M; Salas-Salvadó J; Díaz-López A; Tinahones FJ; Tur JA; Romaguera D; Konieczna J; Pintó X; Daimiel L; Rodriguez-Mateos A; Alfredo Martínez J
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32971870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
    Meng G; Zhang B; Yu F; Li C; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Shi H; Su Q; Gu Y; Fang L; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Jiao H; Wang B; Guo Q; Carvalhoa LA; Sun Z; Song K; Yu M; Niu K
    Eur J Nutr; 2018 Sep; 57(6):2113-2121. PubMed ID: 28702720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.